Sign up for Englemed updates from TwitterSign up for Englemed updates from Facebook
Contact Englemed
Our contact email address.
We can provide a specialist, tailored health and medical news service for your site.
Click here for more information
RSS graphic XML Graphic Add to Google
About Englemed news services - services and policies.
Englemed News Blog - Ten years and counting.
Diary of a reluctant allergy sufferer - How the British National Health Service deals with allergy.
BookshopFor books on women's health, healthy eating ideas, mental health issues, diabetes, etc click here

WWW Englemed
Copyright Notice. All reports, text and layout copyright Englemed Ltd, 52 Perry Avenue, Birmingham UK B42 2NE. Co Registered in England No 7053778 Some photos copyright Englemed Ltd, others may be used with permission of copyright owners.
Disclaimer: Englemed is a news service and does not provide health advice. Advice should be taken from a medical professional or appropriate health professional about any course of treatment or therapy.
Lockdown leads to double unplanned pregnancies
Fri October 22nd - Unplanned pregnancies almost doubled during the first lockdown in the UK, a major study reports today. More
Promising development in treatment for glioblastoma multiforme
Fri October 22nd - A major advance in brain tumour research could pave the way for personalised treatment for the most deadly form of the disease, British scientists say. More
On 09/10/2020 William Haworth wrote:
How long is recovery time after proceedure... on Ablation cuts atrial fibrillat...
On 08/02/2018 David Kelly wrote:
Would you like to write a piece about this to be i... on Researchers unveil new pain re...
On 23/10/2017 Cristina Pereira wrote: on HIV breakthrough - MRC...
On 12/09/2017 Aparna srikantam wrote:
Brilliant finding! indeed a break through in under... on Leprosy research breakthrough...
On 01/07/2017 Annetta wrote:
I have been diagnosed with COPD for over 12 years.... on Seaweed plan for antimicrobial...

Lung transplant feasible for severe COVID-19

Wednesday April 7th 2021

Lung transplants were successfully used to save some COVID-19 patients who developed acute respiratory distress syndrome, it has been revealed.

The procedure was used in at least four countries last year on 12 patients, doctors reported.

The paper appeared in the Lancet Respiratory Medicine recently. It outlines the conditions under which such a transplant can be considered and covers in detail the early outcomes of 12 patients.

Dr Konrad Hoetzenecker, of MedUni Vienna, Austria, and colleagues explain that lung transplant is rarely considered for patients with acute respiratory distress due to infections.

The patients they describe showed severe lung disease from COVID-19 and were deemed at imminent risk of dying. They underwent bilateral lung transplant at hospitals in the USA, Italy, Austria and India from May to September 2020. They were mostly in middle age and a quarter were female.

"The lung transplant procedure was technically challenging," write the authors, but "there was no recurrence of SARS-CoV-2 in the allografts." Their survival rates were similar to those for transplant recipients without a virus.

"Lung transplantation is the only option for survival in some patients with severe, unresolving COVID-19-associated acute respiratory distress syndrome, and the procedure can be done successfully, with good early post-transplantation outcomes, in carefully selected patients," they report.

The team say that potential patients should have exhausted all conservative treatment options, show no recovery of COVID-19-damaged lungs despite at least four weeks of ventilation, be aged below 65 with no major comorbidities, and be in good physical condition.

Dr Hoetzenecker said: "These guidelines can be applied worldwide for making a sound selection of patients who are suitable for a lung transplant following a COVID-19 infection."

Bharat, A. et al. Early outcomes after lung transplantation for severe COVID-19: a series of the first consecutive cases from four countries. The Lancet Respiratory Medicine 31 March 2021 doi: 10.1016/S2213-2600(21)00077-1


Tags: Europe | Flu & Viruses | Respiratory | Transplant | World Health

Printer friendly page Printer friendly page

Comment on this article:

<a>,<b> & <p> tags allowed
Please enter the letters displayed:
(not case sensitive)